Author Archives: Jan Paschal

Braveheart Bio (BRVE) of San Francisco upsized its IPO at pricing and priced the deal at $18.00 – $1.00 above the top of its range – to raise $382.5 million on Wednesday night, Aug. 5, 2026. The Phase 3 biotech’s deal was increased at pricing to 21.25 million shares – up 2.5 million shares – from […]

Attovia Therapeutics (ATTO), a Phase 1 biotech developing drugs to treat chronic itching and IBD, priced its IPO at $17.00 – the top of its range, as expected – and sold 17 million shares – matching the IPO’s upsized terms disclosed this morning – to raise $289 million on Tuesday night, Aug. 4, 2026. At pricing, […]

It’s a supersized Tuesday:   Attovia Therapeutics (ATTO Proposed), a Phase 1 biotech developing drugs to treat chronic pruritis (itching) and IBD, upsized its IPO to $289 million – up from $200 million –  in an S-1/A filing early today (Tuesday, Aug. 4, 2026). The California biotech increased the number of shares to 17 million – up […]

Biotechs are heating up the IPO Calendar as August gets under way. Four big biotech IPOs are set to price this week – along with a smaller biotech deal. Altogether, these five deals aim to raise $972 million. The August heat wave is no surprise. U.S. biotech and pharmaceutical sector IPOs produced a weighted average […]

China’s Londian Wason New Energy Tech (FOIL Proposed) unveiled its plans to raise $75 million in an ADS offering in a filing early today – Monday, Aug. 3, 2026. Londian Wason is one of the world’s largest producers of lithium battery copper foil used in EV batteries as well as in 5G communications, consumer electronics […]

Apnimed (APMD) took its IPO up a notch: The sleep apnea-focused biotech upsized its IPO to 12 million shares – up from 10 million in the prospectus – and priced its IPO at  at $16.00 – the top of its range – to raise $192 million on Thursday night, July 30, 2026. Apnimed increased the […]

Reformation (REF) priced its IPO at $15.00 – the low end of its range – and sold 14.06 million shares – the number of shares in the prospectus – to raise $210.9 million on Wednesday night, July 29, 2026. The price range was $15.00 to $17.00. Reformation’s stock opened flat – at $15.00 – in its […]

Jersey Mike’s Subs (JMKE) priced its IPO at $23.00 – the mid-point of its range – and sold 43.48 million shares – the number in the prospectus – to raise $1 billion on Wednesday night, July 29, 2026. The price range was $21.00 to $25.00. At pricing, Jersey Mike’s Subs had a market cap of $7.3 billion. […]

It’s a battle of the brands right out of central casting. Jersey Mike’s Subs (JMKE Proposed), the iconic sub sandwich brand, hails from the Jersey Shore. Danny Devito – born in the Jersey Shore town of Neptune – stars in Jersey Mike’s commercials.. Reformation (REF Proposed) is a sustainable fashion brand from LA. Taylor Swift loves its “girly girl” dresses.   Together, Jersey Mike’s Subs (JMKE Proposed) and Reformation (REF Proposed)  intend […]

Catalyst Acquisition Corp. (CATLU) raised $200 million with the pricing of its SPAC IPO – 20 million units at $10.00 each – on Monday night, July 27, 2026. Each unit consists of one share of stock and one right to receive one-seventh (1/7th) of a share upon consummation of its initial business combination. Catalyst Acquisition […]